Drug Shortage Report for APO-DILTIAZ CD
Report ID | 121897 |
Drug Identification Number | 02230997 |
Brand name | APO-DILTIAZ CD |
Common or Proper name | DILTIAZ |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL ORAL |
Packaging size | 500 BTL |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-03 |
Estimated end date | 2020-11-27 |
Actual end date | 2020-11-20 |
Shortage status | Resolved |
Updated date | 2020-11-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-11-23 | French | Compare |
v6 | 2020-11-23 | English | Compare |
v5 | 2020-10-30 | French | Compare |
v4 | 2020-10-30 | English | Compare |
v3 | 2020-08-06 | French | Compare |
v2 | 2020-08-06 | French | Compare |
v1 | 2020-08-06 | English | Compare |
Showing 1 to 7 of 7